Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients with bladder cancer will respond to immunotherapy. The discovery, from a new study published in Nature Communications, could improve the survival of bladder cancer patients. Dr. Meeks joins this episode of the Better Edge podcast to discuss the results.
